Instrument Business Outlook Volume 32 - Issue 17
-
Lab Tool M&A Activity Subdued in 2023
-
General M&A Environment
-
Large Targeted Deals Are Few and Far Between
-
Technology Targets
-
New Markets
-
Multiple Acquisitions
-
Private Equity Firms
-
Conclusion
-
Executive Briefing
-
Illumina Submits SEC Filing Regarding GRAIL
-
Avantor Announces Changes and Cost Savings
-
Standard BioTools-SomaLogic Merger Faces Opposition
-
Takara Bio USA Wins EU Patent Hearing
-
Calibre Scientific Aquires Plant Diagnostics Firm
-
BC Platforms Makes Second Purchase This Year
-
Antibody Firm Sold
-
PAC Acquires Process Analyzer Company
-
Third Quarter Results: Biotage, Bio-Techne, HORIBA, Pacific Biosciences and Shimadzu
-
Biotage Concludes Quarter Positively Despite Pockets of Decline
-
Bio-Techne’s Protein Sciences Segment Posts Growth
-
Divisions
-
Regions
-
End-Markets
-
Guidance
-
HORIBA Reaffirms Full-Year 2023 Sales Guidance
-
Pacific Biosciences Optimistic But Cautious for 2024
-
Shimadzu AMI Produces Mixed Results in Asia Pacific
-
Product Lines
-
Geography
-
End-Markets
-
Guidance
-
Market Profile: ICP-MS for Speciation of Arsenic
-
Leading Vendors
-
Largest Markets
-
Instrument Cost
-
Industry Watch
-
Life Sciences: Biopharma Looks Toward 2024
-
R&D: Scientific Publications in 2022
-
Biopharma: US FDA Approves CRISPR Therapy
-
Region Watch
-
China and UK: Survey of UK Businesses
-
France: Major Reforms on the Way
-
UK: New Engineering Biology Plans
-
News
-
Sequencing
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
MS, LC/MS & GC/MS
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Surface Science
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Life Science Instruments
-
Gene-Based Analysis
-
Company Announcements
-
Product Introductions
-
Cell-Based Analysis
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Protein-Based Analysis
-
Company Announcements
-
Sales & Orders of Note
-
Bottom Line